Titan Pharmaceuticals Inc (NAS:TTNP)
$ 4.1 0.13 (3.27%) Market Cap: 3.75 Mil Enterprise Value: -2.50 Mil PE Ratio: 0 PB Ratio: 0.94 GF Score: 40/100

Q3 2020 Titan Pharmaceuticals Inc Earnings Call Transcript

Nov 16, 2020 / 05:00PM GMT
Release Date Price: $69.72 (-1.11%)
Operator

Thank you for holding, and welcome to the Titan Pharmaceuticals Third Quarter 2020 Financial Results Conference Call. Please be advised that this call is being taped at the company's request and will be archived on the company's website starting later today.

At this time, I would like to turn the call over to Dr. Marc Rubin, Executive Chairman of Titan Pharmaceuticals. Please go ahead.

Marc Rubin
Titan Pharmaceuticals, Inc. - Executive Chairman of the Board

Thank you, Sarah. And as always, thank you to all of you for joining us today. Welcome to the Titan Pharmaceuticals Third Quarter 2020 Conference Call.

Before we begin, I want to inform you that we have filed our quarterly report on Form 10-Q with the SEC, and the press release issued earlier today provides a summary of the financial and operational results for the third quarter ending September 30, 2020, and can also be found on our website at www.titanpharm.com.

Joining me on the call today from Titan is Dr.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot